12 Results for "

MAP4K2

" in MedChemExpress (MCE) Product Catalog:
Products (12)

12 Results for "MAP4K2" in MCE Product Catalog:

24
24 Publications Verification
Cat. No.: HY-15434
CAS No.: 1315355-93-1
Purity:  99.35%
Target:  

MAP4K MAP3K

Research Areas:  

Inflammation/Immunology Cancer

NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-77251
CAS No.: 1315330-11-0
Target:  

MAP4K MAP3K

Research Areas:  

Cancer

TAK1/MAP4K2 inhibitor 1 is a potent dual TGFβ-activated kinase 1 (TAK1) and mitogen-activated protein kinase kinase kinase kinase 2 (MAP4K2) inhibitor, with IC50s of 41.1 nM and 18.2 nM, respectively.
loading...
    loading...
Cat. No.: HY-148065
CAS No.: 2769753-07-1
Purity:  98.77%
FMF-06-098-1 is a multi-target kinase PROTAC degrader. FMF-06-098-1 can be used to target degradation kinases which degrades AAK1, AΒL2, AURKA, AURKB, BUBIB, CDC7, CDK1, CDK12, CDK13, CDK2, CDK4, CDk6, CDK7, CDK9, CHEK1, CSNKID, EPHA1, PER, FGFR1, GAK, IRAK4, ITK, LIMK2, MAP4K2, MAP4K3, MAPK6, MAPK7, MARK4, MELK, PKN3, PLK4, PRKAA1, PTK2, PTK6, RPS6KA4, S1K2, STK35, TNK2, UHMK1, ULK1, and WEE1 .
loading...
    loading...
Cat. No.: HY-123714
CAS No.: 1620820-12-3
Purity:  99.55%
Target:  

MAP4K Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

TL4-12 is a selective MAP4K2/GCK inhibitor, dose-dependently downregulates IKZF1 and BCL-6 and leads to MM cell proliferation inhibition (IC50=37 nM) accompanied by induction of apoptosis. TL4-12 can be used to overcome immunomodulatory agent resistance in multiple myeloma (MM) .
loading...
    loading...
Cat. No.: HY-148061
CAS No.: 2769753-53-7
Purity:  99.28%
DB1113 (Example 24) is a bifunctional compound targeted protein degradation of kinases. DB1113 degrades ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2, MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1, RPS6KA1, RPS6KA3, SIK2, SIK3, STK35, TNK2, and ULK1. DB1113 can be used for research of disease or disorder mediated by aberrant kinase activity .
loading...
    loading...
Cat. No.: HY-148063
CAS No.: 2769753-47-9
Purity:  98.80%
DB0614 is a PROTAC based on Cereblon ligand, which is a selective and potent targeted protein degrader of NEK9 inhibitor. DB0614 can degrade ABL1, ABL2, BLK, CDK11B, CDK4, CSK, EPHA3, FER, GAK, LIMK1, MAP3K20, MAP4K1, MAP4K2, MAP4K3, MAP4K5, MAPK14, MAPK7, MAPK8, MAPK9, MAPKAPK2, MAPKAPK3, NLK, PDIK1L, PTK2B, RIPK1, RPS6KA1, RPS6KA3, SIK2, SIK3, STK35, TNK2 and ULK1. DB0614 can be used for research of disease or disorder mediated by aberrant kinase activity .(Blue: Thalidomide-4-OH (HY-103596), Black: linker, Pink: FLT3-IN-17 (HY-148070))
loading...
    loading...
Cat. No.: HY-RS08074
Research Areas:  

Others

MAP4K2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAP4K2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS08075
Research Areas:  

Others

Map4k2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Map4k2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS08076
Research Areas:  

Others

Map4k2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Map4k2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-15434R
CAS No.: 1315355-93-1
Target:  

MAP4K MAP3K

Research Areas:  

Inflammation/Immunology Cancer

NG25 (Standard) is the analytical standard of NG25. This product is intended for research and analytical applications. NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 nM, respectively.
loading...
    loading...
Cat. No.: HY-15434A
CAS No.: 2108554-00-1
Target:  

MAP3K MAP4K

Research Areas:  

Cancer

NG25 trihydrochloride is a dual TAK1 and MAP4K2 inhibitor (IC50: 149 nM and 21.7 nM respectively). NG25 sensitizes the breast cancer cells to Doxorubicin (HY-15142A), and enhances apoptosis. NG25 trihydrochloride can be used for research of various cancers .
loading...
    loading...
Cat. No.: HY-P76946
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Mitogen-activated protein kinase kinase kinase kinase 2; GC kinase; MEKKK 2; GCK; RAB8IP
Species:  
Source:  
loading...
    loading...
  • 1